Literature DB >> 22285847

Induced regulatory T cells: mechanisms of conversion and suppressive potential.

Eefje M Dons1, Giorgio Raimondi, David K C Cooper, Angus W Thomson.   

Abstract

Thymus-derived, naturally occurring CD4(+) Forkhead Box P3(+) regulatory T cells (nTreg) have suppressive activity that is important for the establishment and maintenance of immune homeostasis in the healthy state. Abundant reports have demonstrated that they can suppress pathogenic processes in autoimmune diseases and inhibit transplant rejection and graft-versus-host disease. Far less is known about induced regulatory T cells (iTreg) that are generated from naive T cells in the periphery or in vitro by directing naive T cells to acquire suppressive function under the influence of transforming growth factor-β and other factors. In this review, we describe mechanisms by which naive T cells are thought to be converted into iTreg. We also discuss the suppressive potential of iTreg, particularly in comparison with their naturally occurring counterparts, focusing on those reports in which direct comparisons have been made. Based on current knowledge, we consider the rationale for using iTreg versus nTreg in clinical trials.
Copyright © 2012 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22285847      PMCID: PMC3319286          DOI: 10.1016/j.humimm.2011.12.011

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  92 in total

1.  Genomic definition of multiple ex vivo regulatory T cell subphenotypes.

Authors:  Markus Feuerer; Jonathan A Hill; Karsten Kretschmer; Harald von Boehmer; Diane Mathis; Christophe Benoist
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-15       Impact factor: 11.205

2.  In vitro-expanded donor alloantigen-specific CD4+CD25+ regulatory T cells promote experimental transplantation tolerance.

Authors:  Dela Golshayan; Shuiping Jiang; Julia Tsang; Marina I Garin; Christian Mottet; Robert I Lechler
Journal:  Blood       Date:  2006-09-26       Impact factor: 22.113

3.  Cutting edge: regulatory T cells induce CD4+CD25-Foxp3- T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-beta.

Authors:  Lili Xu; Atsushi Kitani; Ivan Fuss; Warren Strober
Journal:  J Immunol       Date:  2007-06-01       Impact factor: 5.422

4.  IL-2 is essential for TGF-beta to convert naive CD4+CD25- cells to CD25+Foxp3+ regulatory T cells and for expansion of these cells.

Authors:  Song Guo Zheng; Juhua Wang; Pu Wang; J Dixon Gray; David A Horwitz
Journal:  J Immunol       Date:  2007-02-15       Impact factor: 5.422

5.  De novo generation and enhanced suppression of human CD4+CD25+ regulatory T cells by retinoic acid.

Authors:  Jun Wang; Tom W J Huizinga; Rene E M Toes
Journal:  J Immunol       Date:  2009-08-28       Impact factor: 5.422

6.  Infectious tolerance via the consumption of essential amino acids and mTOR signaling.

Authors:  Stephen P Cobbold; Elizabeth Adams; Claire A Farquhar; Kathleen F Nolan; Duncan Howie; Kathy O Lui; Paul J Fairchild; Andrew L Mellor; David Ron; Herman Waldmann
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-30       Impact factor: 11.205

7.  Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells.

Authors:  Angela M Thornton; Patricia E Korty; Dat Q Tran; Elizabeth A Wohlfert; Patrick E Murray; Yasmine Belkaid; Ethan M Shevach
Journal:  J Immunol       Date:  2010-02-24       Impact factor: 5.422

8.  Contrasting effects of cyclosporine and rapamycin in de novo generation of alloantigen-specific regulatory T cells.

Authors:  W Gao; Y Lu; B El Essawy; M Oukka; V K Kuchroo; T B Strom
Journal:  Am J Transplant       Date:  2007-05-19       Impact factor: 8.086

9.  Retinoic acid can enhance conversion of naive into regulatory T cells independently of secreted cytokines.

Authors:  Jens Nolting; Carolin Daniel; Sabine Reuter; Christina Stuelten; Peng Li; Henry Sucov; Byung-Gyu Kim; John J Letterio; Karsten Kretschmer; Hye-Jung Kim; Harald von Boehmer
Journal:  J Exp Med       Date:  2009-09-08       Impact factor: 14.307

10.  PD-L1 regulates the development, maintenance, and function of induced regulatory T cells.

Authors:  Loise M Francisco; Victor H Salinas; Keturah E Brown; Vijay K Vanguri; Gordon J Freeman; Vijay K Kuchroo; Arlene H Sharpe
Journal:  J Exp Med       Date:  2009-12-14       Impact factor: 14.307

View more
  21 in total

1.  Human adipose-derived stromal/stem cells induce functional CD4+CD25+FoxP3+CD127- regulatory T cells under low oxygen culture conditions.

Authors:  Trivia P Frazier; James B McLachlan; Jeffrey M Gimble; Hugh A Tucker; Brian G Rowan
Journal:  Stem Cells Dev       Date:  2014-03-11       Impact factor: 3.272

2.  T-cell receptor sequencing reveals the clonal diversity and overlap of colonic effector and FOXP3+ T cells in ulcerative colitis.

Authors:  James Lord; Janice Chen; Richard C Thirlby; Anna M Sherwood; Christopher S Carlson
Journal:  Inflamm Bowel Dis       Date:  2015-01       Impact factor: 5.325

3.  Directed differentiation of regulatory T cells from naive T cells and prevention of their inflammation-mediated instability using small molecules.

Authors:  M-H Haddadi; B Negahdari; E Hajizadeh-Saffar; M Khosravi-Maharlooei; M Basiri; H Dabiri; H Baharvand
Journal:  Clin Exp Immunol       Date:  2020-06-08       Impact factor: 4.330

4.  Hypoxic culture conditions enhance the generation of regulatory T cells.

Authors:  Thi My Anh Neildez-Nguyen; Jérémy Bigot; Sylvie Da Rocha; Guillaume Corre; Florence Boisgerault; Andràs Paldi; Anne Galy
Journal:  Immunology       Date:  2015-03       Impact factor: 7.397

5.  Ex vivo-expanded cynomolgus macaque regulatory T cells are resistant to alemtuzumab-mediated cytotoxicity.

Authors:  E M Dons; G Raimondi; H Zhang; A F Zahorchak; J K Bhama; L Lu; M Ezzelarab; J N M Ijzermans; D K C Cooper; A W Thomson
Journal:  Am J Transplant       Date:  2013-05-01       Impact factor: 8.086

6.  CX3CR1(+) B cells show immune suppressor properties.

Authors:  Zhiqiang Wu
Journal:  J Biol Chem       Date:  2014-06-26       Impact factor: 5.157

Review 7.  Context and location dependence of adaptive Foxp3(+) regulatory T cell formation during immunopathological conditions.

Authors:  Joshua F Heiber; Terrence L Geiger
Journal:  Cell Immunol       Date:  2012-10-01       Impact factor: 4.868

8.  Influence of tumors on protective anti-tumor immunity and the effects of irradiation.

Authors:  Gemma A Foulds; Jürgen Radons; Mira Kreuzer; Gabriele Multhoff; Alan G Pockley
Journal:  Front Oncol       Date:  2013-02-01       Impact factor: 6.244

9.  Comprehensive microRNA analysis identifies miR-24 and miR-125a-5p as plasma biomarkers for rheumatoid arthritis.

Authors:  Koichi Murata; Moritoshi Furu; Hiroyuki Yoshitomi; Masahiro Ishikawa; Hideyuki Shibuya; Motomu Hashimoto; Yoshitaka Imura; Takao Fujii; Hiromu Ito; Tsuneyo Mimori; Shuichi Matsuda
Journal:  PLoS One       Date:  2013-07-18       Impact factor: 3.240

10.  T-cell regulation in lepromatous leprosy.

Authors:  Kidist Bobosha; Louis Wilson; Krista E van Meijgaarden; Yonas Bekele; Martha Zewdie; Jolien J van der Ploeg-van Schip; Markos Abebe; Jemal Hussein; Saraswoti Khadge; Kapil D Neupane; Deanna A Hagge; Ekaterina S Jordanova; Abraham Aseffa; Tom H M Ottenhoff; Annemieke Geluk
Journal:  PLoS Negl Trop Dis       Date:  2014-04-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.